BioTech IQ

67 Folgen

1. #66 Seasoned Biotech Executive talks T-Cell Therapy and Running a Business in 2023!

   Vom: 26.5.2023
2. #65. A Journey From Investment Banker To The CEO Of A Biotech Developing Cancer Therapy With Bryan Kobel

   Vom: 7.4.2023
3. #64 A Professional Recruiters Perspective on The State of Hiring in Biotech!

   Vom: 17.3.2023
4. #63 From writing a newspaper column at age 7 to becoming a BioTech CEO: Cary Claiborne Sr.

   Vom: 25.2.2023
5. #62 Biotech Consultant Shares Her Thoughts on Where We are Headed: It's About Innovation!

   Vom: 20.1.2023
6. #61 Tunable Radio Pharmaceuticals? The Founders of Ratio Therapeutics.

   Vom: 7.1.2023
7. #60 Biotech Chief People Officer Discusses How To Build Company Culture

   Vom: 18.12.2022
8. BioTech IQ Update

   Vom: 10.12.2022
9. #59 M2GEN's Platform For More Accurate and Faster Oncology Clinical Trial Recruitment

   Vom: 1.11.2022
10. #58 Qualigen Therapeutics: How To Develop An Oncology Therapeutics Pipeline From A CMO's Perspective With Tariq Arshad, MD

    Vom: 21.10.2022
11. Qualigen Therapeutics: Where It All Started And Where It's Going With Founder And CEO Michael Poirier

    Vom: 7.10.2022
12. #56 Qualigen Therapeutics: How Do You Develop A Successful Therapeutics Pipeline In Oncology With Amy Broidrick

    Vom: 16.9.2022
13. #55 Mapping The Human Immune System: Using AI To Change Drug Development With Noam Solomon

    Vom: 5.9.2022
14. #54 Going Beyond The Current Standard Of Care For Anxiety, Depression, And CNS Disorders With Shawn Singh

    Vom: 23.7.2022
15. #53 Harnessing the Innate Immune System By Developing Three Types of iPSC-Derived Natural Killer Cells With Daniel Teper

    Vom: 15.7.2022
16. #52 How is Anima Biotech changing the game on identifying the mechanism of action?

    Vom: 1.7.2022
17. #51 Cell Cycle Therapy: Understanding The Cell Cycle Biology To Treat Cancer With Spiro Rombotis

    Vom: 10.6.2022
18. #50 Can Lineage Cell Therapeutics Proprietary Cell-Based Therapy Platform Change Treatment Development?

    Vom: 27.5.2022
19. #49 Global Tensions And Supply Chains And Their Effect On Biotech. Guillermo Morales, PhD, CEO Of Innoventyx

    Vom: 17.5.2022
20. #48 Market Discussion and Real Life Recruiting Experiences

    Vom: 13.5.2022